Narrative review / 2005
Ephedra was banned by the FDA in 2004 after causing stroke, arrhythmia, and death, while replacement supplements largely lack efficacy and safety data.
This review examines the regulatory framework of the Dietary Supplement Health and Education Act of 1994 (DSHEA) and the history of ephedra, a supplement used for weight loss. Due to sympathomimetic activity, ephedra caused stroke, cardiac arrhythmia, and death, prompting an FDA ban on its sale effective April 12, 2004. An evaluation of other dietary supplements attempting to fill the void demonstrates a general lack of safety and efficacy data. Ten years after DSHEA, the industry remains controversial and a concern for consumer safety.
- Study type
- Narrative review
- Who was studied
- Dietary supplement consumers in the United States
- What was measured
- Ephedra adverse events, regulatory history, and safety/efficacy of replacement supplements
THE PAPER
Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
Seamon MJ, Clauson KA. J Herb Pharmacother, 2005.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.